Current research to overcome T-cell dysfunction in CLL and improve therapies
Diagnosis and Initial Treatment of CLL
Peter Hillmen et al.
The current status of CLL treatment
CheckMate study and the role of nivolumab in Hodgkin lymphoma
KEYNOTE-183 trial of pembrolizumab in multiple myeloma: trial design and rationale